Health Trials

Patient Reported Outcomes Targeting Early Chest Tube Removal (PROTECTR) Study

ConditionsLung SurgeryChest Tube RemovalEnhanced Recovery After Surgery (ERAS)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

About this trial

This study is a single centre, prospective clinical trial evaluating the safety and feasibility of implementing a same day chest tube removal protocol in patients undergoing Video Assisted Thoracic Surgery (VATS) anatomical pulmonary surgery.

Eligibility criteria

Qualifiers

18 yrs or older

scheduled to undergo elective VATS segmental or lobar resection of the lung

Disqualifiers

Pulmonary function tests demonstrating forced expiratory volume in 1 second Forced Expiratory Volume (FEV1) <50% predicted, FEV1 <1.5L and/or diffusion lung capacity of carbon monoxide Lung Diffusion Test (DLCO) <50% predicted

Patient receives an intraoperative pleurodesis

Conversion to open thoracotomy or mini thoracotomy intraoperatively.

Underlying cognitive disorder resulting in inability to complete activities of daily living.

Trial design

Treatments tested in this trial

  • early chest tube removal

Treatment groups

130 Participants
are divided into 2 treatment groups

Sponsors and collaborators

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Lead sponsor

Source ClinicalTrials.gov